More than one suitor might actually lead to a hostil takeover attempt and that would drive stock price up. I do no see partnership possibilities with any US company. Possibly a partnership with an Asian company. All positives in immediate future for Keryx.
I would be very surprised if Amgen is not one of the Companies that tries to acquire us. With their EPO patent runnin out in 2015 we would be a very attractive way to co tinue to dominate dialysis anemia. I just cannot see anything but a bidding war even for partnership. Bring on the patent response and make it convincing Ron!